This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Evaluation Of The GE Monitor Product Line

This study has been withdrawn prior to enrollment.
(Terminated due to lack of enrollment at target sites)
Sponsor:
Information provided by (Responsible Party):
GE Healthcare
ClinicalTrials.gov Identifier:
NCT00730119
First received: August 5, 2008
Last updated: August 7, 2017
Last verified: August 2017
August 5, 2008
August 7, 2017
October 2001
March 2010   (Final data collection date for primary outcome measure)
This investigation will compare values from the test device(s) to itself, or one of the reference parameters, or a combination of parameters, including NIBP, temperature, SpO2, respirations, and ECG. [ Time Frame: unlimited ]
Same as current
Complete list of historical versions of study NCT00730119 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation Of The GE Monitor Product Line
Evaluation Of The GE Monitor Product Line
This investigation is a multi-center study that will demonstrate that the GE Monitor meets equivalency and/or accuracy and/or performance criteria. This investigation will compare the test device(s) to itself, or one of the reference parameters, or a combination of parameters, including NIBP, temperature, SpO2, respirations, and ECG.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
All populations (neonatal, pediatrics, and adults).
  • Non-invasive Blood Pressure
  • Temperature
  • SpO2
  • Respiration
  • ECG
Not Provided
  • Neonates
    Subjects ages birth to 30 days
  • Infants
    Subjects aged >30 days to 2 years
  • Adults
    Subjects aged 18 years of age or older
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
May 2010
March 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Signed informed consent from subject and/or guardian
  • Ability to maintain proper placement of cuff and/or probe and/or sensor
  • Presence of atrial fibrillation or other irregular heart rhythm (when applicable)
  • Ability to single or dual monitor NIBP, ECG, and/or SpO2, whether or not already being monitored for any or all of these parameters (SuperSTAT development study only)

Exclusion Criteria:

  • Any subject deemed too unstable, by clinician's discretion, or for another reason deemed unacceptable for study by the clinician
  • Known dysrhythmias (when applicable)
  • Known disease state or medical condition that A) compromises circulation to the extremity, B) compromises musculo-skeletal integrity, or C) otherwise contraindicates use of a NIBP cuff and/or SpO2 sensor on an extremity or ECG patches on skin
  • Vigorous exercise prior to participating in the study
  • Excessive movement or excitability causing false values or no determinations
  • Known allergy to latex when latex products will be in contact with subject
  • Subjects who have eaten, drank, smoked or chewed gum in the preceding half hour (temperature parameter only)
  • Nasal/septal defects, cold and/or allergies that would not allow the subject to breathe through their nose (temperature parameter only)
  • Subjects with whom flammable anesthetics will be used.
  • Adult/pediatric subjects,(greater than 1 year of age) who, at the clinician's discretion, could not tolerate approximately 12, but no more than 25 blood pressures on each extremity
  • Pediatric/neonatal subjects,(less than 1 year of age) who, at the clinician's discretion, could not tolerate approximately 10, but no more than 12 blood pressures on each extremity
  • Presence of pacemaker which makes the atrial fibrillation rhythm indistinguishable
  • Subject's limb circumference is outside of the manufacturer's recommended cuff range
  • Subject has Korotkoff sounds that persist to nearly zero (when applicable)
Sexes Eligible for Study: All
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00730119
CS 327
No
Not Provided
Not Provided
GE Healthcare
GE Healthcare
Not Provided
Study Director: Jean D Sesing GE Healthcare
GE Healthcare
August 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP